CMB 0.00% 0.4¢ cambium bio limited

Ann: Appendix 3Y Change of Director's Interest Notice, page-10

  1. 118 Posts.
    lightbulb Created with Sketch. 7
    Just answered my own question by watching that interview with the CEO. We will need phase 2 for conditional approval. Interesting for anyone who hasn't seen the interview already. Hopefully shareholders will be pleasantly surprised by some additional licensing deals in Japan over the coming months.
 
watchlist Created with Sketch. Add CMB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.